Pres, Innovation, Tech Aubrey Rankin sold $866K of Revance Therapeutics, Inc.

Sold$865,949

$26.15Price

33,119Shares

−4%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Oct 29. Filed Fri, Oct 30, 4:24 PM ET, after the close. Not investment advice.